Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Midazolam 10mg/1ml oromucosal soln pf oral syringes SF
0408020V0AAASAS
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 2,987 |
|
Epistatus 10mg/1ml oromucosal soln pre-filled oral syringes
0408020V0BCABAS
|
Epistatus | Midazolam maleate | Central Nervous System | 1,709 |
|
Midazolam 10mg/ml oral liquid
0408020V0AAALAL
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 617 |
|
Midazolam 7.5mg/0.75ml oromucosal soln pf oral syringes SF
0408020V0AAAWAW
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 225 |
|
Midazolam 5mg/0.5ml oromucosal soln pf oral syringes SF
0408020V0AAAVAV
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 166 |
|
Midazolam 2.5mg/0.25ml oromucosal soln pf oral syringes SF
0408020V0AAAXAX
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 52 |
|
Epistatus 7.5mg/0.75ml oromucosal soln pf oral syringes
0408020V0BCADAW
|
Epistatus | Midazolam maleate | Central Nervous System | 24 |
|
Epistatus 5mg/0.5ml oromucosal soln pre-filled oral syringes
0408020V0BCACAV
|
Epistatus | Midazolam maleate | Central Nervous System | 22 |
|
Midazolam 12.5mg/5ml oral liquid
0408020V0AAAEAE
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 18 |
|
Midazolam 5mg/5ml oral liquid
0408020V0AAADAD
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 8 |
|
Epistatus 2.5mg/0.25ml oromucosal soln pf oral syringes
0408020V0BCAEAX
|
Epistatus | Midazolam maleate | Central Nervous System | 4 |
|
Midazolam 10mg/5ml oral liquid
0408020V0AAAFAF
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 4 |
|
Midazolam 25mg/5ml oral liquid
0408020V0AAAHAH
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 1 |
|
Midazolam 5mg/0.5ml oromucosal soln pre-filled oral syringes
0408020V0AAATAT
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 1 |
|
Dormicum 15mg tablets
0408020V0BBAAAB
|
Dormicum | Midazolam maleate | Central Nervous System | No data available |
|
Dormicum 7.5mg tablets
0408020V0BBABAC
|
Dormicum | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 11mg/5ml oral liquid
0408020V0AAAMAM
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 15mg tablets
0408020V0AAABAB
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 2.5mg/5ml oral liquid
0408020V0AAAGAG
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 20mg/5ml oral liquid
0408020V0AAAJAJ
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 40mg/5ml oral liquid
0408020V0AAAKAK
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 6.25mg/5ml oral liquid
0408020V0AAAIAI
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg tablets
0408020V0AAACAC
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg/0.75ml oromucosal soln pf oral syringes
0408020V0AAAUAU
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.